Tagged with "medical cannabis"
Technology Trends in the Medical Cannabis Field Tags: technology trends medical cannabis mmj

As more and more states begin to legalize cannabis in some way or another from total recreational legalization, to medical marijuana laws in varying degrees to decriminalization, the industry is ripe for technological advances in terms of how patients receive treatment, how they find their medicine and even in wearables that track a patient’s responses to various strains high in CBDs or through the consumption of oils and edibles.

It is a fledgling industry, not yet available in all 50 states but there are currently 24 states with legalized medical or recreational cannabis on the books, 6 more on the ballots for November and then there is the nation’s capital, the District of Columbia that went legal in recent times. So what then are the technology trends in the medical cannabis field that are having a profound impact on patients? Here are a few.

Digital Connection with Patients

Google, just last year, mandated that everyone with a website should go mobile friendly or be penalized because more people search via mobile devices than via desktop PCs. In fact, walk into any electronics store or even at the computer department of Walmart and you will see maybe one or two ‘all-in- one’ desktops but a wide array of laptops and tablets. You will also find a huge selection of smartphones. This is how cannabis patients search for dispensaries where they can get their medicine and if they are in a new area of their state, it is an invaluable asset to have a mobile friendly site.

However, that is not the only way in which the industry connects with consumers. Almost every dispensary on the face of the earth has a minimum of a Facebook and Twitter account and so the industry uses technology to go social. Information is passed on in this manner for the safe consumption of medical marijuana and specialists in healthcare informatics can track key metrics to gauge where there are high concentrations of patients so as to have a better idea of stocking to supply a need.

Speaking of Metrics – Health Informatics Is a Key Issue

A very large part of getting medical cannabis on the ballot is in providing key metrics to be analyzed by local and state authorities. Being that medical marijuana is a ‘new’ industry, these metrics are critical in measuring a need within society in terms of how people are using the plant and if there is a great enough acceptance within the population to warrant looking into the matter of legalization.

Leading universities offer health informatics graduate degrees and these are the professionals who have the expertise to develop applications that track the success and/or failure of cannabis in treating patients based on a given diagnosis. University of Illinois health informatics is one program that has produced career oriented professionals who have the expertise to design and develop health informatics platforms to assess the needs of cannabis patients in real time.

So then, you could say there are two very distinct ways in which technology trends are impacting the medical cannabis industry. The first is in the dissemination of information to the general public in terms of locating a dispensary and in educational literature as to the pros and cons of medical vs recreational use. However, the biggest impact to the industry is healthcare informatics that provide key metrics in real time that improve patient care as well as provide real and ongoing statistics for analysis by local, state and federal governments. A degree in computer science with a health care focus is without a doubt on the cutting edge of the medical cannabis industry and is one degree in need of concerned healthcare workers and techies alike.

KAIA KUSH
Category: STRAINS
Tags: kaia kush strain medical cannabis sativa hybrid

Apothecary® Genetics Kaia Kush

(Sativa Hybrid)

€100.00 - Pack of 10

Creators:  Apothecary® Genetics

Awards:  1st Place - Cannabis Cup - Amsterdam 2007

Genetics:  MALE OG X SUPER SILVER HAZE

Effect: Smoothing and enjoyable work day medication.

Taste:  Earthy & Spicy

Flowering indoor: 9-10 weeks with a yield of 200-400 gr / sqm

Flowering outdoor - Late November

 

Medical Marijuana in New York? Not Yet, But Assembly Vote Highlights Growing MMJ Support Tags: andrew cuomo and medical cannabis new york medical marijuana bill

 

A measure calling for the legalization and regulation of medical marijuana in New York sailed through the state Assembly yesterday, underscoring growing support for MMJ in the Big Apple.
 
Don’t expect to see medical cannabis in NY anytime soon: The bill faces plenty of opposition in the Senate – where the measure now heads – and the state’s governor has already said he will veto it anyway.
 
But don’t write it off as just a symbolic development, either. This is one tangible and important step in a long process, and it will lay the groundwork for MMJ legalization in the years to come. In other states with MMJ laws, medical marijuana initiatives often failed at first, making small gains along the way until finally winning support of the majority of lawmakers and the governor.
 
How is this any different than the situation in 2007 and 2008, when the NY Assembly also passed medical marijuana bills, to no avail? For one, the entire MMJ landscape has changed since then. Today, 17 states – including several near New York – and the nation’s capital have MMJ laws on the books, and several others could legalize medical cannabis this year. So support for medical marijuana is growing nationally, making it much more acceptable in the public eye.
 
New York Gov. Andrew Cuomo also is trying to reduce state marijuana penalties in general and has left the door open to MMJ legalization down the road, saying he wants to study the issue further before signing off on any bills. Lastly, the current bill has the support of more than 50 lawmakers and was approved by a wide margin in the Assembly, with 90 lawmakers voting for it and 50 voting against it.
 
Put it all together, and the prospects for medical marijuana legalization in New York look a lot better in 2013 or 2014.
 
Scores of Marijuana Dispensaries to Open in Next 6 Months as New MMJ States Come Online Tags: arizona medical marijuana federal crackdown new jersey mmj rhode island medical cannabis vermont mmj washington dc dispensaries

For all the difficulties medical marijuana businesses have experienced in recent times (raids, moratoriums, dispensary bans, you name it), 2012 is actually shaping up to be a pretty good year for the cannabis industry from a national perspective.
 
Four states and the District of Columbia are moving forward with dispensary programs this year after long delays, clearing the way for a new wave of medical marijuana centers to open. Vermont is the latest to head in this direction, officially starting its dispensary application process this week. The state will allow four dispensaries to sell medical marijuana to registered patients.
 
Combined, the states and DC will allow nearly 150 dispensaries and dozens of cultivation operations to set up shop – creating a host of new opportunities and helping to strengthen an industry reeling from a government crackdown. Hundreds of related businesses will also form to support these dispensaries and grow facilities, from hydroponics stores and training facilities to law firms and consultancies.
 
It couldn’t have come at a better time. The Obama administration’s move to shut down dispensaries and put pressure on the industry had created a chilling effect across the country, convincing officials in emerging cannabis states such as Arizona and Rhode Island to put their fledgling MMJ programs on ice or backtrack entirely.
 
But there’s been a real turn-around as of late, and the tide has decidedly changed as these states rejuvenate their MMJ plans.
 
Aside from Vermont, other states moving forward this year with dispensary programs include Arizona, New Jersey, Rhode Island and Washington DC. While most of these areas will allow just a handful of dispensaries, Arizona will license up to 126 – meaning it could quickly join the list of powerhouse MMJ states such as Colorado, California and Washington State.
 
These new businesses will help offset recent industry contraction in California, Colorado and Michigan. They’ll also give MMJ a wider footprint geographically, which could help convince other states to go green as well.
 
Here’s a breakdown showing the number of dispensaries allowed in each of the four new states plus DC:
 
Arizona: 126
 
New Jersey: 6
 
Rhode Island: 3
 
Vermont: 4
 
Washington DC: 5
 
Cannabis Science Announces Critical Cancer Patient Dr. Lynnice Wedewer, Ph.D., Cured Seven Times By Medical Cannabis Tags: Cannabis Science Announces Critical Cancer Patient Dr. Lynnice Wedewer Ph.D. Cured Seven Times By Medical Cannabis

The Company Plans A Documentary Featuring Dr. Lynnice Wedewer, Ph.D., And Other Cancer Patients Being Treated with Medical Cannabis

SOURCE: Cannabis Science Inc.

 

COLORADO SPRINGS, Colo., Jun 29, 2011 (BUSINESS WIRE) -- Cannabis Science Inc. (nasd otcbb:CBIS) a pioneering US biotech company developing pharmaceutical cannabis products, is pleased to announce that it has been contacted by Lynnice Wedewer, Ph.D. who is a 34 year multiple cancer patient survivor who has been cured of 7 of her 8 cancers in a major part because of medical cannabis. Dr. Wedewer wishes to share her story through Cannabis Science and help our case and education towards general acceptance of medical cannabis as a natural and viable treatment for cancer.

In 1979, Iowa passed a medical marijuana law which impacted five children suffering from cancer and who were placed into a cancer treatment program using medical cannabis under the supervision of the University of Iowa. Dr. Wedewer was one of those children and only 1 1/2 years ago did the law in Iowa finally change to allow these patients to finally speak out about their treatment and success stories in battling cancer with medical cannabis.

The Company is excited to feature Dr. Lynnice Wedewer's cancer success story and testimonial in its upcoming documentary, along with other cancer survivors who were cured through the use of medical cannabis.

Dr. Wedewer runs a website www.lynnicewedewer.com where she provides her testimony, speeches, educational material, marijuana facts, interviews and documentaries, and other informational links regarding marijuana.

Dr. Robert Melamede, Ph. D., Cannabis Science Inc., President & CEO said, "These are exciting times to be part of a burgeoning medical marijuana movement and shedding light on patients who are telling their stories and opening up medical files to demonstrate the cancer curing power of medical cannabis. We are enthusiastic and hopefully that Dr. Lynnice Wedewer's testimonial and cancer success along with other patient success stories, including profound medical evidence, will help to educate and finally open up the eyes of federal regulators to decriminalize medical cannabis; so more people's lives can be saved by this natural herbal remedy and stop killing people with man-made pharmaceuticals."

About Cannabis Science, Inc.

Cannabis Science, Inc. is at the forefront of pharmaceutical grade medical marijuana research and development. The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce and commercialize phytocannabinoid-based pharmaceutical products. In sum, we are dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.

This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing works such as "anticipate," "seek," intend," "believe," "plan," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc. does not undertake any duty nor does it intend to update the results of these forward-looking statements.

SOURCE: Cannabis Science Inc.

RSS

 

DISTRIBUTORS

SELECT YOUR COUNTRY

                                    


Questions?

Contact info@apothecarygenetics.com

Consult with me on Maven

Events
There are no upcoming events

This website is powered by Spruz